0 TSX Venture News - December 20, 2018iSIGN Media Announces the Signing of a Health and Medical Industry Agreement with SpeedTrackTORONTO, Dec. 20, 2018 (GLOBE NEWSWIRE) — iSIGN Media Solutions Inc. (“iSIGN” or “Company”) (TSX-V: ISD) (OTC: ISDSF), a leading […]Read More
0 NASDAQ Companies - December 20, 2018Orrstown Financial Services, Inc. Completes $32.5 Million Subordinated Debt OfferingSHIPPENSBURG, Pa., Dec. 20, 2018 (GLOBE NEWSWIRE) — Orrstown Financial Services, Inc. (NASDAQ: ORRF) (“Orrstown”) announced the completion of an […]Read More
0 NYSE Companies - December 20, 2018Matinas BioPharma to Present at Biotech Showcase 2019– Presentation with live audio webcast Monday, January 7th at 3:30 PM PST – BEDMINSTER, N.J., Dec. 20, 2018 (GLOBE […]Read More
0 Canadian Stock Exchange News - December 20, 2018Security Devices International Issues Progress Update on Byrna™ HD Development Timeline and New 2019 Commercial Launch InitiativesSDI Begins Validation Testing and Announces Three New Colors for the Byrna HD Byrna HD Consumer Rollout to Commence at […]Read More
0 Canadian Stock Exchange News - December 20, 2018MGX Minerals Announces Partnership with University of British Columbia to Develop Metallurgical Silicon Based Anode for High-Energy Lithium-Ion BatteriesVANCOUVER, British Columbia, Dec. 20, 2018 (GLOBE NEWSWIRE) — MGX Minerals Inc. (“MGX” or the “Company”) (CSE: XMG / FKT: […]Read More
0 Canadian Stock Exchange News - December 20, 2018Glance Technologies Files Provisional Patent for Blockchain Technology With USPTOVANCOUVER, British Columbia, Dec. 20, 2018 (GLOBE NEWSWIRE) — Glance Technologies Inc. (“Glance” or the “Company”) (CSE:GET.CN) (OTCQB:GLNNF) (FKT:GJT) is […]Read More
0 NYSE Companies - December 20, 2018Global Ship Lease Announces Results of Consent Solicitation for 9.875% First Priority Secured Notes due 2022LONDON, Dec. 20, 2018 (GLOBE NEWSWIRE) — Global Ship Lease, Inc. (NYSE: GSL) (the “Company”) today announced that it has […]Read More
0 NASDAQ Companies - December 20, 2018Sarepta Therapeutics Completes Submission of New Drug Application Seeking Approval of Golodirsen (SRP-4053) in Patients with Duchenne Muscular Dystrophy Amenable to Skipping Exon 53— Golodirsen has been studied for the treatment of exon 53 amenable patients, approximately eight percent of patients with Duchenne […]Read More
0 NASDAQ Companies - December 20, 2018Inpixon On Track to Ship Record Number of IPA Sensor 4000SE in Q4PALO ALTO, Calif., Dec. 20, 2018 (GLOBE NEWSWIRE) — Inpixon (Nasdaq: INPX), a leading indoor positioning and data analytics company, […]Read More
0 NASDAQ Companies - December 20, 2018Galectin Therapeutics Announces Extension of $10 Million Line CreditNORCROSS, Ga., Dec. 20, 2018 (GLOBE NEWSWIRE) — Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target […]Read More